Maria Majdan
Maria Majdan is an expert in Rheumatology at Medical University of Lublin (Poland). As of September 2026, ScienceLeadR ranks Maria Majdan in the top 1% of experts worldwide for Autoimmune Diseases. Maria Majdan has authored 273 publications, the most recent in 2026, and is an investigator in 4 clinical trials. SLR score: 780 (community average: 125). How the SLR is computed.
LeadR Profile
Rheumatology
Subspecialties: Immunology - Dermatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1993 - 2026
Number : 273
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Changes in hematological indices during adalimumab therapy in ankylosing spondylitis: a one-year retrospective study. PMID 42677240 — lymphocytes, spondylitis, ankylosing, retrospective studies, spondylitis, neutrophils, tumor necrosis factor inhibitors, adalimumab, therapeutics, blood platelets | Reumatologia | 2026 | 0 |
| Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis. PMID 39927615 — creatinine, safety, prednisone, lupus nephritis, therapeutics, nephritis | N Engl J Med Top journal | 2025 | 12 |
| Quantification of Citrullinated Histone H3 as a Marker for Neutrophil Extracellular Traps Correlated to Clinical Characteristics of Patients with Systemic Lupus Erythematosus. PMID 39752730 — arthralgia, neutrophils, lupus erythematosus, systemic, histones, complement system proteins, therapeutics, extracellular traps, allergy and immunology | Arch Immunol Ther Exp (Warsz) | 2025 | 0 |
| Lupus anticoagulant as a risk factor of chronic renal failure in patients with systemic lupus erythematosus OpenAlex W4402874006 — anticoagulants, lupus erythematosus, systemic, kidney failure, chronic, lupus coagulation inhibitor, risk factors | Reumatologia | 2024 | 0 |
| Using data from the POLVAS registry to predict individual risk of exacerbations of antineutrophil cytoplasmic antibody associated vasculitis OpenAlex W4402874284 — registries, vasculitis, antibodies, antineutrophil cytoplasmic | Reumatologia | 2024 | 0 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 2
LeadR Networks
Main global connection map